Amphipathic Motifs, Lipoproteins and Atherosclerosis
Project Number3P01HL034343-20S1
Contact PI/Project LeaderSEGREST, JERE P
Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
The central theme of this competitive renewal application for our PPG is based upon three hypotheses: (1)
Apolipoprotein (apo) A-I-containing lipoproteins play a major role in atherogenesis; (2) apoB-containing
lipoproteins play a major role in atherogenesis; and (3) the properties of the different apolipoprotein
domains involved in the regulation of the functions of the apoA-I- and apoB-containing lipoproteins are
determined to a major extent by the properties of the amphipathic motifs ubiquitous to apolipoproteins.
From this we derive our central theme: Amphipathic motifs (the amphipathic a helix and the amphip-
athic P strand/sheet) are fundamentalto a full understandingof the cause and reversal of atherosclerosis.
Amphipathic motifs represent the fundamental paradigm guiding all proposed projects. The objectives in
the nextfive years are to continuedevelopment of a comprehensive theory of the interaction of amphipathic
motifs with lipid and to use this knowledge to: (a) determine the ininirnal structural featuresof apoA-I and
apoE that can prevent and/or reverse atherosclerosis, (b) determine the minimal structural features of apoB
that are involved in both the biosynthesis of apoB-containing lipoproteins and the structure, function and
properties of LDL, and (c) apply this knowledge to understand mechanisms involved in prevention and
reversal of atherosclerosis and potentially for the development of pharmacological agents. To accomplish
these objectives, four projects areproposed: 1)Structure-function ofopoA-I-contoining lipoproteins (Dr.
Jere P. Segrest, Project Leader). 2) Structure and assembly of apoB-containing lipoproteins (Dr. Nassrin
Dashti, Project Leader). 3) Antiatherogenic amphipathic peptides: Structure-function (Dr. G. M.
Anantharamiah, Project Leader). 4)Apolipoproteins andfunctional mimics:in vivo studies (Dr. David W.
Garber, Project Leader). Tosupport these projects, three core faculties areproposed: CoreA:Administra-
tion, Computer and Instrumentation (Dr. Segrest), Core B: Peptide Synthesis and Protein Purification
(Dr. Anantharamaiah), and Core C: MolecularBiology (Dr. Ling Li).
No Sub Projects information available for 3P01HL034343-20S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P01HL034343-20S1
Patents
No Patents information available for 3P01HL034343-20S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P01HL034343-20S1
Clinical Studies
No Clinical Studies information available for 3P01HL034343-20S1
News and More
Related News Releases
No news release information available for 3P01HL034343-20S1
History
No Historical information available for 3P01HL034343-20S1
Similar Projects
No Similar Projects information available for 3P01HL034343-20S1